These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
99 related articles for article (PubMed ID: 8886842)
1. Expression of the bcl-2 gene from a defective HSV-1 amplicon vector protects pancreatic beta-cells from apoptosis. Liu Y; Rabinovitch A; Suarez-Pinzon W; Muhkerjee B; Brownlee M; Edelstein D; Federoff HJ Hum Gene Ther; 1996 Sep; 7(14):1719-26. PubMed ID: 8886842 [TBL] [Abstract][Full Text] [Related]
2. Transfection of human pancreatic islets with an anti-apoptotic gene (bcl-2) protects beta-cells from cytokine-induced destruction. Rabinovitch A; Suarez-Pinzon W; Strynadka K; Ju Q; Edelstein D; Brownlee M; Korbutt GS; Rajotte RV Diabetes; 1999 Jun; 48(6):1223-9. PubMed ID: 10342808 [TBL] [Abstract][Full Text] [Related]
3. Effects of ex vivo transduction of mesencephalic reaggregates with bcl-2 on grafted dopamine neuron survival. Sortwell CE; Bowers WJ; Counts SE; Pitzer MR; Fleming MF; McGuire SO; Maguire-Zeiss KA; Federoff HJ; Collier TJ Brain Res; 2007 Feb; 1134(1):33-44. PubMed ID: 17196186 [TBL] [Abstract][Full Text] [Related]
4. Rapid production of interleukin-2-secreting tumor cells by herpes simplex virus-mediated gene transfer: implications for autologous vaccine production. Tung C; Federoff HJ; Brownlee M; Karpoff H; Weigel T; Brennan MF; Fong Y Hum Gene Ther; 1996 Dec; 7(18):2217-24. PubMed ID: 8953312 [TBL] [Abstract][Full Text] [Related]
5. LacZ gene transfer to skeletal muscle using a replication-defective herpes simplex virus type 1 mutant vector. Huard J; Akkaraju G; Watkins SC; Pike-Cavalcoli M; Glorioso JC Hum Gene Ther; 1997 Mar; 8(4):439-52. PubMed ID: 9054519 [TBL] [Abstract][Full Text] [Related]
6. Ex vivo hepatic gene transfer in mouse using a defective herpes simplex virus-1 vector. Lu B; Gupta S; Federoff H Hepatology; 1995 Mar; 21(3):752-9. PubMed ID: 7875674 [TBL] [Abstract][Full Text] [Related]
7. Gene transfer into hepatocytes mediated by helper virus-free HSV/AAV hybrid vectors. Fraefel C; Jacoby DR; Lage C; Hilderbrand H; Chou JY; Alt FW; Breakefield XO; Majzoub JA Mol Med; 1997 Dec; 3(12):813-25. PubMed ID: 9440115 [TBL] [Abstract][Full Text] [Related]
8. Recombinant fowlpox virus for in vitro gene delivery to pancreatic islet tissue. Solomon MF; Ramshaw IA; Simeonovic CJ Immunol Cell Biol; 2005 Dec; 83(6):615-25. PubMed ID: 16266313 [TBL] [Abstract][Full Text] [Related]
9. Cytotoxicity of a replication-defective mutant of herpes simplex virus type 1. Johnson PA; Miyanohara A; Levine F; Cahill T; Friedmann T J Virol; 1992 May; 66(5):2952-65. PubMed ID: 1373198 [TBL] [Abstract][Full Text] [Related]
11. Generation of high-titer defective HSV-1 vectors using an IE 2 deletion mutant and quantitative study of expression in cultured cortical cells. Lim F; Hartley D; Starr P; Lang P; Song S; Yu L; Wang Y; Geller AI Biotechniques; 1996 Mar; 20(3):460-9. PubMed ID: 8679207 [TBL] [Abstract][Full Text] [Related]
12. Improved herpes simplex virus type 1 amplicon vectors for proportional coexpression of positron emission tomography marker and therapeutic genes. Jacobs AH; Winkeler A; Hartung M; Slack M; Dittmar C; Kummer C; Knoess C; Galldiks N; Vollmar S; Wienhard K; Heiss WD Hum Gene Ther; 2003 Feb; 14(3):277-97. PubMed ID: 12639307 [TBL] [Abstract][Full Text] [Related]
13. Efficient gene transfer to pancreatic islets mediated by adenoviral vectors. Csete ME; Benhamou PY; Drazan KE; Wu L; McIntee DF; Afra R; Mullen Y; Busuttil RW; Shaked A Transplantation; 1995 Jan; 59(2):263-8. PubMed ID: 7839450 [TBL] [Abstract][Full Text] [Related]
14. Defective HSV-1 vector expressing BDNF in auditory ganglia elicits neurite outgrowth: model for treatment of neuron loss following cochlear degeneration. Geschwind MD; Hartnick CJ; Liu W; Amat J; Van De Water TR; Federoff HJ Hum Gene Ther; 1996 Jan; 7(2):173-82. PubMed ID: 8788168 [TBL] [Abstract][Full Text] [Related]
15. Positron emission tomography-based imaging of transgene expression mediated by replication-conditional, oncolytic herpes simplex virus type 1 mutant vectors in vivo. Jacobs A; Tjuvajev JG; Dubrovin M; Akhurst T; Balatoni J; Beattie B; Joshi R; Finn R; Larson SM; Herrlinger U; Pechan PA; Chiocca EA; Breakefield XO; Blasberg RG Cancer Res; 2001 Apr; 61(7):2983-95. PubMed ID: 11306477 [TBL] [Abstract][Full Text] [Related]
16. Cloning of replication-incompetent herpes simplex viruses as bacterial artificial chromosomes to facilitate development of vectors for gene delivery into differentiated neurons. Schmeisser F; Weir JP Hum Gene Ther; 2006 Jan; 17(1):93-104. PubMed ID: 16409128 [TBL] [Abstract][Full Text] [Related]
17. Herpes simplex virus type 1 amplicon vectors with glucocorticoid-inducible gene expression. Lu B; Federoff HJ Hum Gene Ther; 1995 Apr; 6(4):419-28. PubMed ID: 7612699 [TBL] [Abstract][Full Text] [Related]
18. Herpes simplex virus type 1 vector mediated gene transfer to muscle. Huard J; Goins WF; Glorioso JC Gene Ther; 1995 Aug; 2(6):385-92. PubMed ID: 7584113 [TBL] [Abstract][Full Text] [Related]
19. Pure populations of transduced primary human cells can be produced using GFP expressing herpes virus vectors and flow cytometry. Coffin RS; Thomas SK; Thomas NS; Lilley CE; Pizzey AR; Griffiths CH; Gibb BJ; Wagstaff MJ; Inges SJ; Binks MH; Chain BM; Thrasher AJ; Rutault K; Latchman DS Gene Ther; 1998 May; 5(5):718-22. PubMed ID: 9797879 [TBL] [Abstract][Full Text] [Related]
20. Tumor growth inhibition by intratumoral inoculation of defective herpes simplex virus vectors expressing granulocyte-macrophage colony-stimulating factor. Toda M; Martuza RL; Rabkin SD Mol Ther; 2000 Oct; 2(4):324-9. PubMed ID: 11020347 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]